Aditxt, Inc. (NASDAQ:ADTX) Short Interest Update

Aditxt, Inc. (NASDAQ:ADTX) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 180,800 shares, a drop of 82.6% from the November 15th total of 1,040,000 shares. Based on an average daily volume of 2,800,000 shares, the short-interest ratio is presently 0.1 days. Currently, 1.3% of the company’s shares are short sold.

Aditxt Stock Up 2.1 %

Shares of ADTX traded up $0.01 during trading hours on Wednesday, hitting $0.36. 143,379 shares of the stock were exchanged, compared to its average volume of 780,419. The stock’s 50-day moving average price is $0.71 and its two-hundred day moving average price is $30.85. Aditxt has a 12-month low of $0.31 and a 12-month high of $380.00.

Insiders Place Their Bets

In other news, major shareholder Financial Lp Hrt sold 25,534 shares of the company’s stock in a transaction on Wednesday, October 16th. The shares were sold at an average price of $1.17, for a total value of $29,874.78. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.72% of the company’s stock.

About Aditxt

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.